Latest filing published 11 Dec 2025 for Active Biotech AB (publ), €994k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter Thelin is a declared insider of Active Biotech AB (publ) (board member), with filings sourced from Finansinspektionen. Activity is concentrated on a single trading day, 9 December 2025, with 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 11 December 2025, reports a share grant of €994k in Active Biotech AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations